Skip to main content
. 2015 Aug 31;10(8):e0136728. doi: 10.1371/journal.pone.0136728

Fig 3. Effect of rtL269I and other substitutions on resistance to lamivudine (LMV).

Fig 3

(A) HBV DNA constructs were transfected into Huh7 cells, which were treated with LMV for 3 days. The intracellular HBV DNA was prepared for Southern blot analysis. A representative result has been shown. (B) The relative replication levels of each HBV mutant (no drug vs LMV treatment) were calculated based on the results of Figs 2C and 3A. (C) The relative replication ability of the HBV mutants treated with LMV were determined by Southern blotting and quantified by Phosphorimager (*, P < 0.05). The relative replication levels of each HBV construct was shown as the mean value of at least three independent experiments.